Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety

NCT02586363 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Baraclude Tab. 0.5mg, fasting
DRUG: Cavir Tab. 0.5mg, fasting
DRUG: Cavir Tab. 0.5mg, high fatty meal

Sponsor

Seoul St. Mary's Hospital